Unichem Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹400.9
- Today's High:
- ₹433.3
- Open Price:
- ₹433.3
- 52W Low:
- ₹265
- 52W High:
- ₹467
- Prev. Close:
- ₹429.25
- Volume:
- 11658
Company Statistics
- Market Cap.:
- ₹29.38 billion
- Book Value:
- 345.5
- Revenue TTM:
- ₹14.57 billion
- Operating Margin TTM:
- -9.26%
- Gross Profit TTM:
- ₹7.92 billion
- Profit Margin:
- -12.33%
- Return on Assets TTM:
- -3.05%
- Return on Equity TTM:
- -8%
Company Profile
Unichem Laboratories Limited had its IPO on under the ticker symbol UNICHEMLAB.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Unichem Laboratories Limited has a staff strength of 0 employees.
Stock update
Shares of Unichem Laboratories Limited opened at ₹433.3 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹400.9 - ₹433.3, and closed at ₹405.25.
This is a -5.59% slip from the previous day's closing price.
A total volume of 11,658 shares were traded at the close of the day’s session.
In the last one week, shares of Unichem Laboratories Limited have slipped by -3%.
Unichem Laboratories Limited's Key Ratios
Unichem Laboratories Limited has a market cap of ₹29.38 billion, indicating a price to book ratio of 0.9306 and a price to sales ratio of 1.8286.
In the last 12-months Unichem Laboratories Limited’s revenue was ₹14.57 billion with a gross profit of ₹7.92 billion and an EBITDA of ₹-144077504. The EBITDA ratio measures Unichem Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Unichem Laboratories Limited’s operating margin was -9.26% while its return on assets stood at -3.05% with a return of equity of -8%.
In Q2, Unichem Laboratories Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 36.7%.
Unichem Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹-25.35 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Unichem Laboratories Limited’s profitability.
Unichem Laboratories Limited stock is trading at a EV to sales ratio of 1.8017 and a EV to EBITDA ratio of 26.6364. Its price to sales ratio in the trailing 12-months stood at 1.8286.
Unichem Laboratories Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹31.93 billion
- Total Liabilities
- ₹6.40 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Unichem Laboratories Limited ended 2024 with ₹31.93 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹31.93 billion while shareholder equity stood at ₹24.35 billion.
Unichem Laboratories Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹6.40 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹15.45 million in goodwill. Its cash balance stood at ₹1.84 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹636.49 million.
Unichem Laboratories Limited’s total current assets stands at ₹15.88 billion while long-term investments were ₹0 and short-term investments were ₹48.53 million. Its net receivables were ₹5.89 billion compared to accounts payable of ₹2.91 billion and inventory worth ₹6.25 billion.
In 2024, Unichem Laboratories Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Unichem Laboratories Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹405.25
- 52-Week High
- ₹467
- 52-Week Low
- ₹265
- Analyst Target Price
- ₹
Unichem Laboratories Limited stock is currently trading at ₹405.25 per share. It touched a 52-week high of ₹467 and a 52-week low of ₹467. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹399.49 and 200-day moving average was ₹352.68 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5289.9% of the company’s stock are held by insiders while 767.8% are held by institutions.
Frequently Asked Questions About Unichem Laboratories Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.